GCG and heart failure: Taking this into account, our study aimed to analyze different clinical trials done on a glucagon-like peptide-1 agonist, namely liraglutide, to understand its effects on the various outcomes of heart failure and to realize its potential as a pharmacological therapy for heart failure in patients with and without other comorbidities.